ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Aging and Cellular Mechanism for Insulin Action After Exercise Training

This study has been completed.

Sponsored by: Department of Veterans Affairs
Information provided by: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00018239
  Purpose

This study will determine whether the metabolic and cellular mechanisms contributing to improved insulin action after aerobic or resistive exercise are different in older, obese, insulin resistant veterans. The hypothesis is that regular exercise, whether aerobic or resistive, will improve whole body insulin action, but the nature and magnitude of changes in skeletal muscle will differ between the two types of exercise.


Condition Intervention
Diabetes Mellitus
Procedure: Exercise

MedlinePlus related topics:   Diabetes    Exercise and Physical Fitness   

ChemIDplus related topics:   Insulin   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Uncontrolled, Single Group Assignment, Efficacy Study
Official Title:   Aging and Cellular Mechanism for Insulin Action After Exercise Training

Further study details as provided by Department of Veterans Affairs:

Study Start Date:   October 1999
Estimated Study Completion Date:   September 2002

Detailed Description:

Veterans will be of comparable body composition and age, and randomly assigned to either aerobic or resistive exercise. They will be instructed in a weight maintenance diet prior to beginning the exercise program, and maintain this diet throughout the study. Metabolic testing will be performed at baseline and after 6 months of exercise training. Testing will include measurement of body composition (anthropometry, dual-energy Xray absorptiometry, computed tomograph scan), maximal oxygen consumption, and muscle strength, glucose tolerance (oral glucose tolerance test), insulin sensitivity (euglycemic-hyperinsulinemic clamp), and muscle biopsies to examine skeletal muscle metabolic characteristics (fiber type distribution, capillary density, oxidative and glycolytic enzyme activities, and levels of key proteins important in insulin signaling and glucose transport). Data will be analyzed using analysis of variance to determine differences between the two exercise groups, and multiple regression analysis to determine the primary adaptations that are associated with the improvements in whole body insulin action.

  Eligibility
Ages Eligible for Study:   50 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Males between 50 years and 80 years

Overweight

Non-smoker

Sedentary (no regular exercise for one year)

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00018239

Locations
United States, Maryland
VA Maryland Health Care System    
      Baltimore, Maryland, United States, 21201

Sponsors and Collaborators

Investigators
Investigator:     Andrew P Goldberg, M.D.    
  More Information


Study ID Numbers:   AGCG-001-99S
First Received:   July 3, 2001
Last Updated:   June 23, 2005
ClinicalTrials.gov Identifier:   NCT00018239
Health Authority:   United States: Federal Government

Study placed in the following topic categories:
Metabolic Diseases
Diabetes Mellitus
Endocrine System Diseases
Endocrinopathy
Metabolic disorder
Glucose Metabolism Disorders
Insulin

ClinicalTrials.gov processed this record on October 10, 2008




Links to all studies - primarily for crawlers